Nevada
|
0-30379
|
88-0425691
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01
|
Entry into a Material Definitive Agreement
|
Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) |
Exhibits.
|
Exhibit
|
Description
|
|
Amendment No. 1 dated March 20, 2019 between Chembio Diagnostics, Inc. and
Javan Esfandiari
, amending the Employment Agreement dated March 5, 2016
|
CHEMBIO DIAGNOSTICS, INC.
|
||
Dated: March 25, 2019
|
By:
|
/s/ John J. Sperzel III
|
John J. Sperzel III
|
||
Chief Executive Officer and President
|
Javan Esfandiari
|
Chembio Diagnostics, Inc.
|
||
/s/ Javan Esfandiari |
By:
|
/s/ John J. Sperzel III
|
|
Chief Executive Officer and President
|